The year of 2006 is soon coming to an end, and for IASLC it has been a very successful year. The Journal of Thoracic Oncology (JTO) has been launched and has developed successfully over the year. PUBMED approval is expecting to happen in early 2007 and all the published articles will then be retrospectively listed. The IASLC has added about 1000 new members within the last year. Significant new activities have been initiated including the hiring of a public relations company to help IASLC formulate and make the IASLC policy effective. Several scientifically focused meetings/workshops were held during the year with great success and the organization has expanded educational activities in South America and Asia in collaboration with local societies in harmony with the overall objectives for this global organization. After having site visited very good candidates for hosting the 14th World Conference on Lung Cancer the Board of Directors recently selected Amsterdam to host the World Conference in 2011 and preparations have already started. The IASLC Fellowship Program has expanded this year and there are now 17 fellowships in lung cancer research available (see below). The IASLC staging committee has recently finalized and submitted a proposal to UICC for a New International Staging System for Lung Cancer, a significant achievement, which effort has been chaired by Professor Peter Goldstraw, UK. The passing year also brought fruitful collaborative discussions with other major cancer organizations like American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO). Thus, the platform for fulfilling the fundamental ideas of IASLC has been solid through the past year. The IASLC Executive Office and the IASLC Board of Directors wish all the IASLC members a happy, healthy and successful year in 2007, and as an organization we are looking forward to a new year in prosperity and growth.
Best wishes for 2007
Fred R. Hirsch, MD, PhD
Deadline for Fellowship Applications: January 5, 2007 – please e-mail your application!!!
3rd IASLC/ASCO/ESMO International Conference on Targeted Therapies in Lung Cancer, November 8-12, 2006
The 3rd IASLC/ASCO/ESMO Conference on Targeted Therapies was held in Taormina, Sicily with participation from about 200 opinion leaders and representatives of the pharmaceutical industry. Many new agents are currently in early clinical development and the conference gave the participants an update with the opportunity to discuss future strategy. New agents in the pipelines were also presented and discussed. Selection of patients to the new targeted therapies was a subject of focus during the conference as well as sessions on biomarker assessments, including technical aspects. The organizers plan to summarize the information presented for a special supplement of JTO.
IASLC/CRPF Prevention/Translational Research Fellowship Award
2 years duration.
IASLC Lung Cancer Fellowship Award/Young Investigators Award
2 years duration
The IASLC is proud to announce a continuation and expansion of the IASLC Fellowship and Young Investigators Programs. Overall there are 17 potential awards for two years each. There are 4 awards in prevention and translational lung cancer research that are jointly sponsored with the Cancer Research and Prevention Foundation (CRPF) through educational grants from Eli Lilly (3) and Bristol-Myers Squibb (1). There are 13 unrestricted awards in any field of lung cancer research supported by educational grants from GlaxoSmithKline (3), Sanofi-Aventis (3), AstraZeneca (3), Pfizer (1), Eli Lilly (1), OSI (1) and EMD Pharmaceuticals (1). This year 8 new unrestricted awards of $40,000 each year for 2 years are available for competition. We are now requesting application for these Fellowships and Young Investigator awards to be awarded in 2007. The goal is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. The applications will be evaluated by a Scientific Review Panel; the deadline for submission of the application is January 5, 2007. A decision on applications will be reached by March 2007. Application forms can be found at the website: www.iaslc.org Please e-mail you application to: pia.Hirsch@uchsc.edu latest January 5, 2007
IASLC Staging Committee proposal to new UICC International Staging
Classification for Lung Cancer
After several years of dedicated work under the scientific leadership of Professor Peter Goldstraw, UK and with financial support from Eli Lilly and company, the IASLC Staging Committee has most recently finalized the proposal for new international staging classification for lung cancer. The proposal has been sent to the UICC and proposed as the “UICC 6th edition of the International Staging System (ISS) for Lung Cancer (ICD-O C34). This is a significant achievement and congratulations goes to all the participants in this multidisciplinary project, which has been coordinated by Drs. Peter Goldstraw, John Crowley, Patti Groome, Pieter Postmus, Ramon Rami-Porta, Valerie Rusch and Leslie Sobin. The full database, which includes 100.869 submitted cases from all parts of the World, is located with Cancer Research and Biostatistics (CRAB) organization based in Seattle, US. The final document can be found at www.crab.org/IASLC/UICC/menu.pdf
Coming IASLC Work-shops
January 23-26, 2007 BTOG Meeting Place: Dublin, Ireland Contact: Ken O'Byrne, MD Email: firstname.lastname@example.org
February 16-17, 2007 Pisa Lung Cancer Conference Contact: Andrea Ardizzoni Email: email@example.com
February 22-24, 2007 IASLC Targeted Therapies for the Treatment of Lung Cancer Place: Santa Monica, CA USA Chairs: Paul A. Bunn, Jr., David Johnson and Roy Herbst For more information, please contact Pia Hirsch at firstname.lastname@example.org Please visit www.thecbce.com
September 2-6, 2007 The 12th World Conference on Lung Cancer - IASLC Place: Seoul, Korea Contact: Conference Secretariat E-mail: email@example.com For more information, please visit www.2007worldlungcancer.org
November 3-6, 2007 Turkish Thoracic Society Place: Istanbul, Turkey Contact: Muzaffer Metintas, MD Email: firstname.lastname@example.org
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - San Francisco, Calif.December 4 2015San Francisco, California
January 4 - 7 2016San Diego, CA
February 17 - 20 2016Santa Monica, California